Sugi Predict

Sugi Predict / Compounds / SCHEMBL17817668

SCHEMBL17817668

SCHEMBL17817668

CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(O)=C(O)C1=O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.70
▸ HSPD1 P10809 1/20 0.70
▸ HSPE1 P61604 1/20 0.70
▸ TST Q16762 1/20 0.70
▸ RECQL P46063 1/20 0.70
▸ BLM P54132 1/20 0.70
▸ TDP1 Q9NUW8 1/20 0.70
▸ PPM1A P35813 2/20 0.49
▸ LMNA P02545 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ DUSP3 P51452 1/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ ENPP2 Q13822 4/20 0.46
▸ LPAR6 P43657 1/20 0.46
▸ LPAR1 Q92633 1/20 0.46
▸ LPAR4 Q99677 1/20 0.46
▸ LPAR5 Q9H1C0 1/20 0.46
▸ LPAR2 Q9HBW0 1/20 0.46
▸ LPAR3 Q9UBY5 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL285433 1.00 MAPT (0.70) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL2460004 1.00 MAPT (0.70) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL4388035 0.90 MAPT (0.55) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL14252495 0.84 MAPT (0.72) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL8472638 0.82 MAPT (1.00) MAPTHSPD1HSPE1TSTRECQL
Ascorbyl Stearate SCHEMBL4574542 0.82 MAPT (1.00) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL1762372 0.82 MAPT (1.00) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL1762325 0.82 MAPT (1.00) MAPTHSPD1HSPE1TSTRECQL
Ascorbyl Palmitate SCHEMBL11170086 0.82 MAPT (1.00) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL22749146 0.82 MAPT (1.00) MAPTHSPD1HSPE1TSTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11857557-B2 Oral dissolvable film containing vitamin D3 CUREX PHARMACEUTICAL MEXICO S.A.P.I. DE C.V. (MX) 2024-01-02 — — US disclosed
US-20210145849-A1 ORAL DISSOLVABLE FILM CONTAINING VITAMIN D3 CURE PHARMACEUTICAL HOLDING CORP. (US) 2021-05-20 — — US disclosed
EP-3229811-B1 PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS GRI BIO INC (US) 2021-02-24 — — EP disclosed
WO-2016094226-A1 PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS GLYCOREGIMMUNE, INC. (US) 2016-06-16 — — WO disclosed
US-20160158258-A1 PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS ALTIUM GROWTH FUND, LP 2016-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210145849-A1 ORAL DISSOLVABLE FILM CONTAINING VITAMIN D3 CYP24A1, CYP2R1, VDR MAPT 2053/4885HSPD1 95/4885HSPE1 868/4885
US-20160158258-A1 PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS RXRA, RXRG, CX3CR1 MAPT 4762/4885HSPD1 3832/4885HSPE1 2991/4885
US-11857557-B2 Oral dissolvable film containing vitamin D3 CYP24A1, CYP2R1, VDR MAPT 2053/4885HSPD1 95/4885HSPE1 868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.